StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$10.41−1.33 (-11.33%)

Close on Nov 18, 2026Market cap $70.68MP/E –Yield –

Eloxx Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Eloxx Pharmaceuticals's operating cash flow for the twelve months ending Dec 31, 2023 was -$14.34M. For fiscal 2025 it was -$6.33M. The highest annual figure on record is -$3.68M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.33M–
FY2024Dec 31, 2024-$4.72M–
FY2023Dec 31, 2023-$14.34M–
FY2022Dec 31, 2022-$31.85M–
FY2021Dec 31, 2021-$35.00M–
FY2020Dec 31, 2020-$28.17M–
FY2019Dec 31, 2019-$39.39M–
FY2018Dec 31, 2018-$31.37M–
FY2016Jun 30, 2016-$3.68M–
FY2015Jun 30, 2015-$7.34M–
FY2014Jun 30, 2014-$4.87M–
FY2013Jun 30, 2013-$3.90M–
FY2012Jun 30, 2012-$4.39M–
FY2011Jun 30, 2011-$5.39M–
FY2010Jun 30, 2010-$4.74M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$4.79M–
Q1 FY2026CQ1 2026Mar 31, 2026-$5.45M–
Q2 FY2025CQ2 2025Jun 30, 2025-$1.75M–
Q1 FY2025CQ1 2025Mar 31, 2025$1.20M–
Q4 FY2023CQ4 2023Dec 31, 2023-$2.01M–
Q3 FY2023CQ3 2023Sep 30, 2023-$3.45M–
Q2 FY2023CQ2 2023Jun 30, 2023-$2.07M–
Q1 FY2023CQ1 2023Mar 31, 2023-$6.81M–
Q4 FY2022CQ4 2022Dec 31, 2022-$5.66M–
Q3 FY2022CQ3 2022Sep 30, 2022-$6.95M–
Q2 FY2022CQ2 2022Jun 30, 2022-$9.75M–
Q1 FY2022CQ1 2022Mar 31, 2022-$9.49M–
Q4 FY2021CQ4 2021Dec 31, 2021-$9.93M–
Q3 FY2021CQ3 2021Sep 30, 2021-$7.59M–
Q2 FY2021CQ2 2021Jun 30, 2021-$9.80M–
Q1 FY2021CQ1 2021Mar 31, 2021-$7.69M–
Q4 FY2020CQ4 2020Dec 31, 2020-$4.67M–
Q3 FY2020CQ3 2020Sep 30, 2020-$5.26M–
Q2 FY2020CQ2 2020Jun 30, 2020-$6.32M–
Q1 FY2020CQ1 2020Mar 31, 2020-$11.92M–
Q4 FY2019CQ4 2019Dec 31, 2019-$9.26M–
Q3 FY2019CQ3 2019Sep 30, 2019-$11.32M–
Q2 FY2019CQ2 2019Jun 30, 2019-$9.62M–
Q1 FY2019CQ1 2019Mar 31, 2019-$9.19M–
Q4 FY2018CQ4 2018Dec 31, 2018-$9.06M–
Q3 FY2018CQ3 2018Sep 30, 2018-$8.10M–
Q2 FY2018CQ2 2018Jun 30, 2018-$8.51M–
Q1 FY2018CQ1 2018Mar 31, 2018-$5.70M–
Q4 FY2016CQ2 2016Jun 30, 2016-$714.79K–
Q3 FY2016CQ1 2016Mar 31, 2016-$840.98K–
Q2 FY2016CQ4 2015Dec 31, 2015-$988.30K–
Q1 FY2016CQ3 2015Sep 30, 2015-$1.13M–
Q4 FY2015CQ2 2015Jun 30, 2015-$2.42M–
Q3 FY2015CQ1 2015Mar 31, 2015-$1.45M–
Q2 FY2015CQ4 2014Dec 31, 2014-$1.53M–
Q1 FY2015CQ3 2014Sep 30, 2014-$1.94M–
Q4 FY2014CQ2 2014Jun 30, 2014-$1.22M–
Q3 FY2014CQ1 2014Mar 31, 2014-$1.56M–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?